Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
17.7
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
14.5
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
0.76
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.5221
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
0.4693
EC/CAS
25956-17-6
Name of the chemical
Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate (17); (CI 16035)
Concentration
0.2436
General Information
Revision date
2020-07-08
Product name
RUKOBIA EXTENDED RELEASE TABLETS
Product Synonyms
FOSTEMSAVIR 600 MG EXTENDED RELEASE TABLETS * BMS-663068 ER TABLETS 600 MG *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Sensitization, skin Category 1B Specific target organ toxicity, repeated Category 2 exposure
Environmental hazards
Not classified. OSHA defined hazards Not classified.
Signal word
Warning
Hazard statements
May cause an allergic skin reaction. May cause damage to organs through prolonged or repeated exposure.
Prevention
Do not breathe dust/fume/gas/mist/vapors/spray. Contaminated work clothing must not be allowed out of the workplace. Wear protective gloves.
Response
If on skin: Wash with plenty of water/. Get medical advice/attention if you feel unwell. If skin irritation or rash occurs: Get medical advice/attention. Wash contaminated clothing before reuse.
Storage
Not available.
Disposal
Dispose of contents/container (in accordance with related regulations). Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
20.972% of the mixture consists of component(s) of unknown acute oral toxicity. 97.472% of the mixture consists of component(s) of unknown acute dermal toxicity. 97.472% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 97.472% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
